开始使用胰高血糖素样肽-1 激动剂时减少或停用胰岛素或磺酰脲类药物

{"title":"开始使用胰高血糖素样肽-1 激动剂时减少或停用胰岛素或磺酰脲类药物","authors":"Emily Herron","doi":"10.12788/fp.0452","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":513268,"journal":{"name":"Federal Practitioner","volume":"170 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reducing or Discontinuing Insulin or Sulfonylurea When Initiating a Glucagon-like Peptide-1 Agonist\",\"authors\":\"Emily Herron\",\"doi\":\"10.12788/fp.0452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":513268,\"journal\":{\"name\":\"Federal Practitioner\",\"volume\":\"170 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Federal Practitioner\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12788/fp.0452\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Federal Practitioner","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/fp.0452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}